Meanwhile,
Update pharmacy medicinal list: virpax new: For example,
Update pharmacy medicinal list: virpax:
Specialties made available to direct access to pharmacies.Dragos Condrea / iStock/Getty Images Plus / via Getty Images
L’National Agency for the Safety of Medicines and Health Products (ANSM) updated the list of pharmacy medicines by decision of 3 July 2025 [1]. Therefore,
The specialties registered on this list can be advised by the pharmacist. In addition, without medical prescriptionand they can be put to disposition in direct access to patients in pharmacies.
Treatment of Labial Herpes recurrences in adults – Update pharmacy medicinal list: virpax – Update pharmacy medicinal list: virpax new
In the classroom “Skin disorders (herpes) »the. specialty Virpax 50 mg Muco-Adhesive Buccogingival tablet update pharmacy medicinal list: virpax new is added to already registered aciclovir specialties.
VIRPAX is indicated in the treatment of recurrences of Labial update pharmacy medicinal list: virpax herpes in immunocompetent. adults with frequent herpes thrusts.
This specialty is distinguished by its original galenic shape In Buccoging Muco-Adhesive tablet to apply in the canine pit. of the upper gum. A single tablet should be applied within an hour after the first symptoms (burns, tingling, itching) and signs (redness, swelling).
VIERPAX is indicated in adults only.
Symptomatic treatment of reflux. a new reference for a topical NSAID
Among the other specialties registered in July 2025, we can cite :
- L’Antacids GAVISCONPRO MINT oral suspension in box of 10 and 20 sachets (alginate de sodium/bicarbonate de potassium) : this medication is Indicated in the symptomatic treatment of gastroesophageal reflux such as acidic regurgitation, stomach burns and difficult digestion (reflux linked), for update pharmacy medicinal list: virpax new example after meals, or during pregnancy, or in patients with symptoms related to esophagian reflux ;
- The non-steroidal anti-steroidal anti-inflammatory update pharmacy medicinal list: virpax Voltarenactigo 1 % gel in 60 g tube (diclofenac): the presentation bearing the CIP 34009 code37230353 is registered to replace that bearing the CIP code 3400936354081.

.
Two other specialties are registered. but they are not marketed at 17 July 2025:
- Pramocaine chlorhydrate arrow council 1 % Gel for local application (hemorrhoidal crisis) ;
- ALGINATE DE SODIUM/BICARBONATE DE SODIUM ARROW CONSEIL 500 mg/267 mg pour 10 mL sans sucre oral suspension in sachet sweetened with sodium saccharin (antacid).
Further reading: Lead exposure harms children’s memory – Skin samples could detect Parkinson’s disease up to seven years before the appearance of symptoms – Be careful if you get stuck by a tick: this symptom that can go unnoticed is the first update pharmacy medicinal list: virpax new sign of Lyme disease &ndash. Slowned jacket and backpack | More weight, more results – App to find people, panels to orient themselves … Singapore at point to take care of Alzheimer’s patients.
Further reading: The strong gesture of this association in Marmande for research on a rare genetic disease – Confirmation of a case of Aboriginal chikungunya – If you want to stay mentally lively at 80, say goodbye now to these 7 habits – Doing sports thanks to household chores reduces the risk of mortality up to 40 % (study) – PRAC recommends a softening of hematological monitoring.
